In 2007, the United States entered its twenty-sixth year since the beginning of the HIV/AIDS epidemic with approximately 1.2 million people living with HIV/AIDS. The development of a HIV vaccine is complicated by a formidable array of biological, political, economic, logistical, and ethical issues.